Chemotherapy is usually used in combination with radiation therapy?to treat gliomas. The chemotherapy drug used most often to treat gliomas is temozolomide (Temodar), which is taken as a pill. Side effects of chemotherapy depend on the type and dose of drugs you receive.
This report contains market size and forecasts of Glioma Treatment in global, including the following market information:
Global Glioma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glioma Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Glioma Treatment companies in 2021 (%)
The global Glioma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ChemOthersapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glioma Treatment include Sun Pharmaceutical, Amgen, Teva Pharmaceutical, Bristol-Myers Squibb, Pfizer, Merck, Eli Lilly, F. Hoffmann-La Roche Ltd and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Glioma Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioma Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Type, 2021 (%)
ChemOthersapy
Drugs
Global Glioma Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Cancer Research Organizations
Diagnostic Centers
Others
Global Glioma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glioma Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioma Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glioma Treatment revenues share in global market, 2021 (%)
Key companies Glioma Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Glioma Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharmaceutical
Amgen
Teva Pharmaceutical
Bristol-Myers Squibb
Pfizer
Merck
Eli Lilly
F. Hoffmann-La Roche Ltd
AbbVie
Genentech
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila
Takeda Pharmaceuticals
Boston Biomedical
Ziopharm Oncology
Celldex Therapeutics
BERG
Oncorus
Agenus
Deciphera Pharmaceuticals
Karyopharm Therapeutics
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Glioma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glioma Treatment Overall Market Size
2.1 Global Glioma Treatment Market Size: 2021 VS 2028
2.2 Global Glioma Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glioma Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Glioma Treatment Players in Global Market
3.2 Top Global Glioma Treatment Companies Ranked by Revenue
3.3 Global Glioma Treatment Revenue by Companies
3.4 Global Glioma Treatment Sales by Companies
3.5 Global Glioma Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glioma Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glioma Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glioma Treatment Players in Global Market
3.8.1 List of Global Tier 1 Glioma Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Glioma Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Glioma Treatment Market Size Markets, 2021 & 2028
4.1.2 ChemOthersapy
4.1.3 Drugs
4.2 By Type - Global Glioma Treatment Revenue & Forecasts
4.2.1 By Type - Global Glioma Treatment Revenue, 2017-2022
4.2.2 By Type - Global Glioma Treatment Revenue, 2023-2028
4.2.3 By Type - Global Glioma Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Glioma Treatment Sales & Forecasts
4.3.1 By Type - Global Glioma Treatment Sales, 2017-2022
4.3.2 By Type - Global Glioma Treatment Sales, 2023-2028
4.3.3 By Type - Global Glioma Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Glioma Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Glioma Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Cancer Research Organizations
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Glioma Treatment Revenue & Forecasts
5.2.1 By Application - Global Glioma Treatment Revenue, 2017-2022
5.2.2 By Application - Global Glioma Treatment Revenue, 2023-2028
5.2.3 By Application - Global Glioma Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Glioma Treatment Sales & Forecasts
5.3.1 By Application - Global Glioma Treatment Sales, 2017-2022
5.3.2 By Application - Global Glioma Treatment Sales, 2023-2028
5.3.3 By Application - Global Glioma Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Glioma Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Glioma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Glioma Treatment Revenue & Forecasts
6.2.1 By Region - Global Glioma Treatment Revenue, 2017-2022
6.2.2 By Region - Global Glioma Treatment Revenue, 2023-2028
6.2.3 By Region - Global Glioma Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Glioma Treatment Sales & Forecasts
6.3.1 By Region - Global Glioma Treatment Sales, 2017-2022
6.3.2 By Region - Global Glioma Treatment Sales, 2023-2028
6.3.3 By Region - Global Glioma Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Glioma Treatment Revenue, 2017-2028
6.4.2 By Country - North America Glioma Treatment Sales, 2017-2028
6.4.3 US Glioma Treatment Market Size, 2017-2028
6.4.4 Canada Glioma Treatment Market Size, 2017-2028
6.4.5 Mexico Glioma Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Glioma Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Glioma Treatment Sales, 2017-2028
6.5.3 Germany Glioma Treatment Market Size, 2017-2028
6.5.4 France Glioma Treatment Market Size, 2017-2028
6.5.5 U.K. Glioma Treatment Market Size, 2017-2028
6.5.6 Italy Glioma Treatment Market Size, 2017-2028
6.5.7 Russia Glioma Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Glioma Treatment Market Size, 2017-2028
6.5.9 Benelux Glioma Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Glioma Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Glioma Treatment Sales, 2017-2028
6.6.3 China Glioma Treatment Market Size, 2017-2028
6.6.4 Japan Glioma Treatment Market Size, 2017-2028
6.6.5 South Korea Glioma Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Glioma Treatment Market Size, 2017-2028
6.6.7 India Glioma Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Glioma Treatment Revenue, 2017-2028
6.7.2 By Country - South America Glioma Treatment Sales, 2017-2028
6.7.3 Brazil Glioma Treatment Market Size, 2017-2028
6.7.4 Argentina Glioma Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glioma Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Glioma Treatment Sales, 2017-2028
6.8.3 Turkey Glioma Treatment Market Size, 2017-2028
6.8.4 Israel Glioma Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Glioma Treatment Market Size, 2017-2028
6.8.6 UAE Glioma Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sun Pharmaceutical
7.1.1 Sun Pharmaceutical Corporate Summary
7.1.2 Sun Pharmaceutical Business Overview
7.1.3 Sun Pharmaceutical Glioma Treatment Major Product Offerings
7.1.4 Sun Pharmaceutical Glioma Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Sun Pharmaceutical Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Glioma Treatment Major Product Offerings
7.2.4 Amgen Glioma Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Corporate Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Glioma Treatment Major Product Offerings
7.3.4 Teva Pharmaceutical Glioma Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Teva Pharmaceutical Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Glioma Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Glioma Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Glioma Treatment Major Product Offerings
7.5.4 Pfizer Glioma Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Glioma Treatment Major Product Offerings
7.6.4 Merck Glioma Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Glioma Treatment Major Product Offerings
7.7.4 Eli Lilly Glioma Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Glioma Treatment Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Glioma Treatment Sales and Revenue in Global (2017-2022)
7.8.5 F. Hoffmann-La Roche Ltd Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Glioma Treatment Major Product Offerings
7.9.4 AbbVie Glioma Treatment Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Genentech
7.10.1 Genentech Corporate Summary
7.10.2 Genentech Business Overview
7.10.3 Genentech Glioma Treatment Major Product Offerings
7.10.4 Genentech Glioma Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Genentech Key News
7.11 BioMimetix
7.11.1 BioMimetix Corporate Summary
7.11.2 BioMimetix Glioma Treatment Business Overview
7.11.3 BioMimetix Glioma Treatment Major Product Offerings
7.11.4 BioMimetix Glioma Treatment Sales and Revenue in Global (2017-2022)
7.11.5 BioMimetix Key News
7.12 Cipla
7.12.1 Cipla Corporate Summary
7.12.2 Cipla Glioma Treatment Business Overview
7.12.3 Cipla Glioma Treatment Major Product Offerings
7.12.4 Cipla Glioma Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Cipla Key News
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Corporate Summary
7.13.2 Sigma-Aldrich Glioma Treatment Business Overview
7.13.3 Sigma-Aldrich Glioma Treatment Major Product Offerings
7.13.4 Sigma-Aldrich Glioma Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Sigma-Aldrich Key News
7.14 Panacea Biotec
7.14.1 Panacea Biotec Corporate Summary
7.14.2 Panacea Biotec Business Overview
7.14.3 Panacea Biotec Glioma Treatment Major Product Offerings
7.14.4 Panacea Biotec Glioma Treatment Sales and Revenue in Global (2017-2022)
7.14.5 Panacea Biotec Key News
7.15 Zydus Cadila
7.15.1 Zydus Cadila Corporate Summary
7.15.2 Zydus Cadila Business Overview
7.15.3 Zydus Cadila Glioma Treatment Major Product Offerings
7.15.4 Zydus Cadila Glioma Treatment Sales and Revenue in Global (2017-2022)
7.15.5 Zydus Cadila Key News
7.16 Takeda Pharmaceuticals
7.16.1 Takeda Pharmaceuticals Corporate Summary
7.16.2 Takeda Pharmaceuticals Business Overview
7.16.3 Takeda Pharmaceuticals Glioma Treatment Major Product Offerings
7.16.4 Takeda Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2017-2022)
7.16.5 Takeda Pharmaceuticals Key News
7.17 Boston Biomedical
7.17.1 Boston Biomedical Corporate Summary
7.17.2 Boston Biomedical Business Overview
7.17.3 Boston Biomedical Glioma Treatment Major Product Offerings
7.17.4 Boston Biomedical Glioma Treatment Sales and Revenue in Global (2017-2022)
7.17.5 Boston Biomedical Key News
7.18 Ziopharm Oncology
7.18.1 Ziopharm Oncology Corporate Summary
7.18.2 Ziopharm Oncology Business Overview
7.18.3 Ziopharm Oncology Glioma Treatment Major Product Offerings
7.18.4 Ziopharm Oncology Glioma Treatment Sales and Revenue in Global (2017-2022)
7.18.5 Ziopharm Oncology Key News
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Corporate Summary
7.19.2 Celldex Therapeutics Business Overview
7.19.3 Celldex Therapeutics Glioma Treatment Major Product Offerings
7.19.4 Celldex Therapeutics Glioma Treatment Sales and Revenue in Global (2017-2022)
7.19.5 Celldex Therapeutics Key News
7.20 BERG
7.20.1 BERG Corporate Summary
7.20.2 BERG Business Overview
7.20.3 BERG Glioma Treatment Major Product Offerings
7.20.4 BERG Glioma Treatment Sales and Revenue in Global (2017-2022)
7.20.5 BERG Key News
7.21 Oncorus
7.21.1 Oncorus Corporate Summary
7.21.2 Oncorus Business Overview
7.21.3 Oncorus Glioma Treatment Major Product Offerings
7.21.4 Oncorus Glioma Treatment Sales and Revenue in Global (2017-2022)
7.21.5 Oncorus Key News
7.22 Agenus
7.22.1 Agenus Corporate Summary
7.22.2 Agenus Business Overview
7.22.3 Agenus Glioma Treatment Major Product Offerings
7.22.4 Agenus Glioma Treatment Sales and Revenue in Global (2017-2022)
7.22.5 Agenus Key News
7.23 Deciphera Pharmaceuticals
7.23.1 Deciphera Pharmaceuticals Corporate Summary
7.23.2 Deciphera Pharmaceuticals Business Overview
7.23.3 Deciphera Pharmaceuticals Glioma Treatment Major Product Offerings
7.23.4 Deciphera Pharmaceuticals Glioma Treatment Sales and Revenue in Global (2017-2022)
7.23.5 Deciphera Pharmaceuticals Key News
7.24 Karyopharm Therapeutics
7.24.1 Karyopharm Therapeutics Corporate Summary
7.24.2 Karyopharm Therapeutics Business Overview
7.24.3 Karyopharm Therapeutics Glioma Treatment Major Product Offerings
7.24.4 Karyopharm Therapeutics Glioma Treatment Sales and Revenue in Global (2017-2022)
7.24.5 Karyopharm Therapeutics Key News
8 Global Glioma Treatment Production Capacity, Analysis
8.1 Global Glioma Treatment Production Capacity, 2017-2028
8.2 Glioma Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Glioma Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glioma Treatment Supply Chain Analysis
10.1 Glioma Treatment Industry Value Chain
10.2 Glioma Treatment Upstream Market
10.3 Glioma Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glioma Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Glioma Treatment in Global Market
Table 2. Top Glioma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glioma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glioma Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Glioma Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Glioma Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glioma Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Glioma Treatment Product Type
Table 9. List of Global Tier 1 Glioma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Glioma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glioma Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glioma Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glioma Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Glioma Treatment Sales (K Units), 2023-2028
Table 16. By Application - Global Glioma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glioma Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glioma Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glioma Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Glioma Treatment Sales (K Units), 2023-2028
Table 21. By Region - Global Glioma Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glioma Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glioma Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glioma Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Glioma Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glioma Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Glioma Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glioma Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glioma Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glioma Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glioma Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glioma Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Glioma Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glioma Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glioma Treatment Sales, (K Units), 2023-2028
Table 46. Sun Pharmaceutical Corporate Summary
Table 47. Sun Pharmaceutical Glioma Treatment Product Offerings
Table 48. Sun Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Glioma Treatment Product Offerings
Table 51. Amgen Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Corporate Summary
Table 53. Teva Pharmaceutical Glioma Treatment Product Offerings
Table 54. Teva Pharmaceutical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Glioma Treatment Product Offerings
Table 57. Bristol-Myers Squibb Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Glioma Treatment Product Offerings
Table 60. Pfizer Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Glioma Treatment Product Offerings
Table 63. Merck Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly Glioma Treatment Product Offerings
Table 66. Eli Lilly Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. F. Hoffmann-La Roche Ltd Corporate Summary
Table 68. F. Hoffmann-La Roche Ltd Glioma Treatment Product Offerings
Table 69. F. Hoffmann-La Roche Ltd Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie Glioma Treatment Product Offerings
Table 72. AbbVie Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Genentech Corporate Summary
Table 74. Genentech Glioma Treatment Product Offerings
Table 75. Genentech Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. BioMimetix Corporate Summary
Table 77. BioMimetix Glioma Treatment Product Offerings
Table 78. BioMimetix Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Cipla Corporate Summary
Table 80. Cipla Glioma Treatment Product Offerings
Table 81. Cipla Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Sigma-Aldrich Corporate Summary
Table 83. Sigma-Aldrich Glioma Treatment Product Offerings
Table 84. Sigma-Aldrich Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Panacea Biotec Corporate Summary
Table 86. Panacea Biotec Glioma Treatment Product Offerings
Table 87. Panacea Biotec Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Zydus Cadila Corporate Summary
Table 89. Zydus Cadila Glioma Treatment Product Offerings
Table 90. Zydus Cadila Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Takeda Pharmaceuticals Corporate Summary
Table 92. Takeda Pharmaceuticals Glioma Treatment Product Offerings
Table 93. Takeda Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Boston Biomedical Corporate Summary
Table 95. Boston Biomedical Glioma Treatment Product Offerings
Table 96. Boston Biomedical Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Ziopharm Oncology Corporate Summary
Table 98. Ziopharm Oncology Glioma Treatment Product Offerings
Table 99. Ziopharm Oncology Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Celldex Therapeutics Corporate Summary
Table 101. Celldex Therapeutics Glioma Treatment Product Offerings
Table 102. Celldex Therapeutics Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. BERG Corporate Summary
Table 104. BERG Glioma Treatment Product Offerings
Table 105. BERG Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Oncorus Corporate Summary
Table 107. Oncorus Glioma Treatment Product Offerings
Table 108. Oncorus Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 109. Agenus Corporate Summary
Table 110. Agenus Glioma Treatment Product Offerings
Table 111. Agenus Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 112. Deciphera Pharmaceuticals Corporate Summary
Table 113. Deciphera Pharmaceuticals Glioma Treatment Product Offerings
Table 114. Deciphera Pharmaceuticals Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 115. Karyopharm Therapeutics Corporate Summary
Table 116. Karyopharm Therapeutics Glioma Treatment Product Offerings
Table 117. Karyopharm Therapeutics Glioma Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 118. Glioma Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 119. Global Glioma Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Glioma Treatment Production by Region, 2017-2022 (K Units)
Table 121. Global Glioma Treatment Production by Region, 2023-2028 (K Units)
Table 122. Glioma Treatment Market Opportunities & Trends in Global Market
Table 123. Glioma Treatment Market Drivers in Global Market
Table 124. Glioma Treatment Market Restraints in Global Market
Table 125. Glioma Treatment Raw Materials
Table 126. Glioma Treatment Raw Materials Suppliers in Global Market
Table 127. Typical Glioma Treatment Downstream
Table 128. Glioma Treatment Downstream Clients in Global Market
Table 129. Glioma Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Glioma Treatment Segment by Type
Figure 2. Glioma Treatment Segment by Application
Figure 3. Global Glioma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Glioma Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glioma Treatment Revenue in 2021
Figure 9. By Type - Global Glioma Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glioma Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Glioma Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glioma Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Glioma Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glioma Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glioma Treatment Sales Market Share, 2017-2028
Figure 19. US Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glioma Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glioma Treatment Sales Market Share, 2017-2028
Figure 24. Germany Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glioma Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glioma Treatment Sales Market Share, 2017-2028
Figure 33. China Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glioma Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glioma Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glioma Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glioma Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glioma Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glioma Treatment by Region, 2021 VS 2028
Figure 50. Glioma Treatment Industry Value Chain
Figure 51. Marketing Channels
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)